Skip to content

Gilead Sciences GILD Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$21M-320%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$278K-21.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$21K-138%
CG Oncology logo
CG OncologyCGON
-$46K-126%
Incyte logo
IncyteINCY
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$167.41B+20.4%
Enterprise value$181.96B+14.5%
P/E18.2×-3.9×
P/S5.6×+0.8×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's other noncash income (expense)?
Gilead Sciences (GILD) reported other noncash income (expense) of -$183M in Q1 2026.
How has Gilead Sciences's other noncash income (expense) changed year-over-year?
Gilead Sciences's other noncash income (expense) decreased by 101.1% year-over-year, from -$91M to -$183M.
What is the long-term trend for Gilead Sciences's other noncash income (expense)?
Over 4 years (2021 to 2025), Gilead Sciences's other noncash income (expense) has grown at a -5.3% compound annual growth rate (CAGR), from -$597M to -$480M.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.